Nursing Home News — Page 360

The medication was Clotrimazole and Betamethasone, a combination antifungal and corticosteroid cream available only by prescription.

The deficiency was classified at Scope and Severity Level D, meaning inspectors identified an isolated problem.

The equipment citation, recorded under a category covering environmental deficiencies, was one of the inspection's more straightforward findings on paper.

Or if they did, they didn't act like it mattered much.

These are not luxury accommodations.

Federal health inspectors visited the nursing home on October 29, 2025, following a complaint.

The gap between what should have been communicated and what the record showed was complete.

The patch, delivering 10 micrograms of buprenorphine per hour, had been placed on the resident's chest on September 30, 2025.

The inspection, completed October 31, 2025, was triggered by a complaint.

On the morning of October 30, she told inspectors she did not believe the facility had provided him with individualized dementia care.

Federal inspectors documented the problem during a complaint inspection on November 14, 2025.

The citation, tagged F0689 at the level of actual harm, affected a small number of residents.